lines growing either in vivo or in vitro. HTLV-I viral products were not detected in 3 of 4 transplantable cell lines proliferating in vivo. Peripheral blood T cells immortalized by introduction of tax gene of HTLV-I were found t o have no turnorigenic potential in SClD mice. These data suggest that (1) HTLV-l-infected cell lines of nonleukemic cell origin do not have enough leukemogenic changes t o acquire the tumorigenic potential in SCID mice; (2) the IL-2 autocrine mechanism is not directly involved in the tumor cell growth; (3) viral gene expression is not needed for the maintenance of neoplastic cell growth; and (4) the expression of tax gene is not sufficient for the neoplastic cell growth in vivo. Here, we show that some HTLV-I-infected cell lines can engraft in SCID mice. In addition, we have also studied the relationship between the HTLV-I viral expression and tumorigenicity and the involvement of IL-2 autocrine mechanism in the neoplastic cell growth in SCID mice.
MATERIALS AND METHODS

Mice.
Immune-deficient SCID (CBI7scidlscid) mice were obtained from Nihon Clea Inc (Tokyo, Japan). The mice were bred and maintained under specific pathogen-free conditions in the animal facility of the Institute for Virus Research, Kyoto University (Kyoto, Japan).
Cells. ED-40515(+) is an IL-2-dependent T-cell line of leukemic cell origin established from an ATL patient." ED-40515(-) is a subclone of ED-40515(+) and does not require exogenous 1L-2 for its growth." SY is an HTLV-I-infected T-cell line derived from a nonleukemic cell clone from the same ATL patient and requires exogenous 1L-2 for its growth. ATL-43T (M. Maeda et al, manuscript in preparation) is an IL-2-dependent T-cell line established from double-negative (CD4-, CD8-) leukemic cells from a patient with ATL." ED-405 15(+), ED40515(-), and ATL-43T leukemic T-cell lines were established by M. Maeda + indicates that serum soluble human IL-2 R a chain (Tac) levels in mice are greater than 10,000 pg/mL.
vector DGL were obtained as previously de~cribed.2~ Both infectants were maintained in AIM-V medium (Life Technologies, Inc, Grand Island, NY) supplemented with 10% FCS containing 0.5 nmol/L recombinant human IL-2. Two populations of DGL-Tax1 infectants were used in this study. Population 1 and population 2 had been maintained in growth medium for about 3 years and for 4 months, respectively, after the infection with DGL-Taxl, and both were then kept frozen in liquid nitrogen until use. Injection of the cells info SCID mice. Cells (2.5 to 20 X IO' ) were washed three times with RPM11640 medium containing 10% FCS. These cells were finally resuspended in 0.5 mL of RPM11640 medium containing 10% FCS and were intraperitoneally injected into SCID mice.
Measurement of serum soluble hwnan IL2Ra chain (Tac) levels. Blood periodically obtained from the tail and also blood from the heart of a killed mouse were used for the measurement of soluble human IL-2Ra chain (kc). Serum soluble Tac levels were measured by enzyme-linked immunosorbent assay (ELISA) as previously described.15
Flow cytometric analysis. Fluorescein isothiocyanate (FITC)-or phycoerythrin (PE)-conjugated murine monoclonal antibodies (MoAbs) to human CD2 (LeuSb), CD3 (Leu4), CD4 (Leu3a), and CD8 (Leu2a) were purchased from Becton Dickinson (San Jose, CA). The MoAb to the a chain of human IL-2R, anti-Ta~?~.~' was used as FITC-conjugated IgG. Cell suspensions were washed in Hanks' Balanced Salt Solution (HBSS) containing 1% bovine serum albumin (BSA) and 0.1% NaN3 and stained with saturating amounts of MoAbs as previously described.15 The stained cells were analyzed on a FACScan (Becton Dickinson & CO, Mountain View, CA).
Southern blot hybridization. DNA was prepared from the cells or tissues by proteinase K digestion followed by phenol chloroform extraction. DNA was then digested with the restriction enzyme EcoRI (Toyobo, Osaka, Japan), electrophoresed in a 0.7% agarose gel, and blotted to a Hybond-N membrane (Amersham International, Buckinghamshire, UK). The membranes were hybridized with randomly primed 32P-labeled DNA probes in a buffer containing 50% formamide and 6X SSC at 42"C, washed finally in 0 . 1~ SSC/O.l% sodium dodecyl sulfate (SDS) at 65"C, and exposed to x-ray film at -70°C. Two probes were used in the present study. One was a 0.96-kb Acc VSma I fragment of HTLV-I pX region2* and the other was a 3.5-kb HindIIIIEcoRI fragment that contained human T-cell receptor (TCR) Cp, gene.29
Northern blot hybridization. Total cellular RNA was isolated by the acid-guanidium thiocyanate-phenol-chloroform method." Ten micrograms of total RNA was fractionated in a l% agaroselformaldehyde denaturing gel and was transferred to a Hybond-N membrane. The membranes were hybridized with 32P-labeled DNA probes in a buffer containing 50% formamide and 5X SSPE at 42"C, washed finally in 0.1X SSC/O.l% SDS at 50°C (for the detection of IL-2 mRNA) or 65°C (for the detection of HTLV-I and p-actin mRNAs), and exposed to x-ray film. To detect HTLV-I and IL-2 mRNAs, a 0.96-kb Acc IISm I fragment of HTLV-I pX region and HinfI fragment of pIL-2*50A3' were used, respectively. Human pactin cDNA probe was purchased from Clontech (Palo Alto, CA).
Reverse transcription-polymerase chain reaction (RT-PCR).
Single-strand cDNA was synthesized from 1 pg of total RNA using avian myeloblastosis virus reverse transcriptase (Midwest Bio-Products, Inc, Covington, IN) and o l i g~( d T )~~. ,~ primer (Pharmacia, Uppsala, Sweden) in a volume of 20 pL, as previously de~cribed.~' The cDNA preparation was then diluted to 100 pL. Two and one-half microliters of cDNA was amplified in a volume of 25 pL in the presence of 800 nmol/L 5' and 3' primers, 200 prnoVL dNTPs, 1U
Taq polymerase (TAKARA, Otsu, Japan), and PCR buffer containing 10 mmol/L Tris-HCI (pH 8.3), 50 mmoVL KC1, and 2.5 mmol/L MgC12. The PCR primers specific for L -2 were purchased from Clontech. The primers (RPX3 and RPX4) were used to amplify HTLV-I pX (taxhex) mRNA as previously described.33 For the human-specific &actin amplification, the following primers were used: forward primer (5'-CCGCAAAGACCTGTACGCCA) and inverse primer (5'-TGGACITGGGAGAGGACTGG). The amplification was performed in a thermal cycler (Perkin Elmer Cetus, Norwalk, CT) for 25 or 30 cycles. The cycling conditions were 1 minute at 94°C for denaturation, 1 minute at 60°C for annealing, and 2 minutes at 72°C for elongation. To rule out false-positive results due to DNA contamination, we ran negative control without RT. The amplified products were then visualized after electrophoresis through 1.0% agarose13.0 % NuSieve GTG agarose (FMC BioProducts, Rockland, ME) gels by staining with ethidium bromide.
Histopathology. The tumors and other tissues of interest fixed
For personal use only. on November 16, 2017. by guest www.bloodjournal.org From in 10% formalin were processed to 4-pm paraffin wax-embedded sections for staining with hematoxylin and eosin (H&E). In contrast, the remaining 7 cell lines failed to form tumors in SCID mice during a 3-to 6-month follow-up period. Histologic examination showed the infiltration of tumor cells in lymph nodes, liver, diaphragm, pericardium, and peripheral blood in SCID-ED-40515(+) mice and in lymph nodes, thymus, lungs, spleen, and pleural fluids in SCID-ATL-43T mice. In addition, we found tumor cells in lymph nodes, thymus, spleen, and liver in SCID-HUT102 mice. In contrast to SCID-ED-405 15(+), -ATL-43T, and -HUT102 mice in which tumor cells infiltrated into various organs, SCID-ED-40515(-) mice were found to have a solitary tumor in peritoneal cavity and the infiltration into other organs was minimal ( Table 1 and Fig 1) . However, 6 HTLV-I-infected cell lines derived from the nonleukemic cells could not engraft in SCID mice. As summarized in Table 2 , we found the engraftment of 3 of 4 HTLV-I-infected cell lines derived from the leukemic cells and no engraftment of 6 HTLV-I-infected cell lines of nonleukemic cell origin. Concerning the relationship between the dependency of cell growth in vitro on exogenous IL-2 and the tumorigenicity, 2 of 4 IL-2-dependent cell lines and 2 of 7 IL-2-independent cell lines showed the tumorigenicity in SCID mice without the supply of exogenous IL-2.
RESULTS
Histopathologic examination
Serum soluble human IL-2Ra chain (Tac) levels as indicators of cell proliferation in vivo. Serum soluble Tac levels measured periodically were increased in mice that were found to be engrafted with HTLV-I-infected cell lines with the tumor development, whereas the nonengrafted mice showed no increase ( Table 1 and Fig 2) .
Flow cvtometric analysis. To determine whether the cells proliferating in the mice were the same clone as the original cell line, we examined the cell surface phenotype of the cells recovered from the tumor, peripheral blood, and pleural fluids (data not shown). It was shown that the phenotype of tumor cells was the same as that of the original cell line ( Table 2) .
DNA analysis. To confirm that the cells proliferating in SCID mice were the same clone as the original cell line, Southern blot hybridization analysis using HTLV-I pX and Cp, of human TCR as probes was performed. As shown in (Fig 5) . To determine the sensitivity of RT-PCR for HTLV-I mRNA detection, total RNA from HUT102 cells was serially diluted with Jurkat cell RNA (Fig 5) . Total RNA from Jurkat cells stimulated with phytohemagglutinin (PHA) and phorbo1 myristate acetate (PMA) was serially diluted with MOLT-4 cell RNA to determine the sensitivity of RT-PCR for IL-2 mRNA detection (data not shown). HTLV-I mRNA in HUT102 cell RNA and IL-2 mRNA in stimulated Jurkat cell RNA were still detectable at a 500-fold dilution. In HUT102 cells, the expression of HTLV-I gene appeared to be downregulated in vivo as compared with the expression in vitro (Fig 4) .
SClD-ED-40515(-)
SCID-ATL-43T Table 3 ).
DISCUSSION
We found that 4 of 11 HTLV-I-infected cell lines were capable of proliferating and infiltrating into various organs in SCID mice that were neither treated with TM-P1 MoAb nor supplied with exogenous human recombinant IL-2. Three [ED-40515(+), ED-40515(-), and ATL-43TI of 4 cell lines that successfully engrafted in SCID mice are derived from the leukemic cell clone, and the clonal origin of the remaining one (HUT102) is, unfortunately, unclear and no longer can be determined. Six of seven HTLV-I-infected reported in ATL.37 However, it has been reported that point mutations of the p53 gene were detected in a considerable proportion of ATL case^.^^.^' Such a genetic change may be one of the critical changes responsible for the development of ATL. A model of the in vivo cell proliferation of ATL cells we present here would be useful in identifying such changes.
One of the most interesting and unexpected findings in the present study is that some HTLV-I-infected cell lines derived from the leukemic clone that can grow in vitro only with the supply of exogenous IL-2 successfully engrafted in SCID mice and showed tumorigenicity without exogenous IL-2. It is unlikely that a sufficient amount of murine IL-2 is produced in SCID mice that lack both mature T and B cells. Moreover, murine IL-2 is not effective in human systems. In addition, Northern blot hybridization and RT-PCR analysis of these cell lines growing either in vitro or in vivo did not show the expression of IL-2 mRNA. In our previous studies using fresh leukemic cells from ATL patients, we injected exogenous human recombinant IL-2 into SCID mice to support their cell growth in vivo." However, subsequent studies showed that the supply of exogenous IL-2 was not necessarily prerequisite to the successful engraftment of fresh leukemic cells in SCID mice (unpublished data). These observations are consistent with our data that leukemic cells from only 20% to 30% of ATL patients examined proliferated in response to exogenous IL-2'" and no IL-2 mRNA was detected in peripheral blood leukemic cells from ATL patienk4" Collectively, it appears that the IL-2 autocrine system is not directly involved in the neoplastic cell growth of the leukemic cells in ATL, although the involvement of the abnormalities of the intracellular IL-2 signaling pathway in the neoplastic cell growth cannot be ruled out. It would be of interest and importance to identify the factor(s) that supports the cell growth of HTLV-I-infected and IL-2-dependent cells in vivo instead of exogenous IL-2.
We then examined HTLV-I viral gene expression of cell line cells proliferating in vivo compared with that of cells growing in vitro. It has been suggested that,viral products are not required for the neoplastic cell growth because viral gene expression is usually undetectable or at a very low level in fresh ATL In our studies, any species of HTLV-I mRNA was not detected in ED-40515(+), ED-405 l5(-), and ATL-43T cells proliferating either in vivo or in vitro. In addition to genomic, env, and pX (taxhex) mRNAs, mRNAs for tof (p30"), p13", and p12' that have For personal use only. on November 16, 2017. by guest www.bloodjournal.org From reported r e~e n t l y~~. '~ can be detected by HTLV-I probe (nt 7368-8328), which we used for Northern blot analysis. These data appear to support the notion that HTLV-I viral products are not essential for the maintenance of neoplastic cell growth of HTLV-I-infected cells in vivo.
A unique viral product, p40ta", which is encoded by tax gene of HTLV-I, has the potential to trans-activate many cellular genes and HTLV-I itself through the interaction with at least three different transcription factors, NF-KB," CREB, 45 and It has been reported that mesenchymal tumors but not leukemia/lymphoma are induced in transgenic mice that express the authentic ~40'"" 47 and the introduction of tax gene into primary T cells resulted in their immortalization in
We injected T cells immortalized by infection with tax-expressing retrovirus vector into SCID mice pretreated with TM-,f31 MoAb to test the possible involvement of ~40'"" in the neoplastic cell growth in vivo. However, the cells we tested could not successfully engraft in SCID mice and the elevation of serum soluble Tac level was not observed, indicating that the expression of tax gene is not sufficient for the induction of the cell growth in vivo. Thus, our SCID mouse model enabled us to distinguish the tumorigenicity of HTLV-I-infected cells from the in vitro immortalization and would provide us a good opportunity to study and identify the oncogenic changes that are triggered by HTLV-I infection and eventually lead to the development of ATL.
